2019
DOI: 10.3390/ma12213576
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force

Abstract: Magnetic nanoparticles have great prospects for drug delivery purposes, as they can be designed with various surface coatings and conjugated with drugs and targeting moieties. They also have a unique potential for precise delivery when guided by magnetic force. The blood-brain barrier (BBB) denotes the interface between the blood and brain parenchyma and hinders the majority of drugs from entering the brain. Red fluorescent magnetic nanoparticles were encapsulated in liposomes and conjugated to antibodies targ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 66 publications
0
13
0
Order By: Relevance
“…Here we used liposomes functionalized with OX26, a well-known antibody against the rat TfR, which does not compete with endogenous transferrin (Pardridge 2015). In previous work, the OX26 antibody has shown good specificity toward the rat TfR both in vitro and in vivo, and liposomes conjugated with the OX26 antibody have shown good targeting ability toward the brain microvasculature in post-natal rats (Johnsen et al 2017;Thomsen et al 2019). In the present work, we have combined intravenous injection of Anti-TfR liposomes with FUS-induced increase of BBB permeability to investigate if this approach enhanced the delivery of the Anti-TfR liposomes across the BBB compared with liposomes lacking the targeting moiety.…”
Section: Discussionmentioning
confidence: 99%
“…Here we used liposomes functionalized with OX26, a well-known antibody against the rat TfR, which does not compete with endogenous transferrin (Pardridge 2015). In previous work, the OX26 antibody has shown good specificity toward the rat TfR both in vitro and in vivo, and liposomes conjugated with the OX26 antibody have shown good targeting ability toward the brain microvasculature in post-natal rats (Johnsen et al 2017;Thomsen et al 2019). In the present work, we have combined intravenous injection of Anti-TfR liposomes with FUS-induced increase of BBB permeability to investigate if this approach enhanced the delivery of the Anti-TfR liposomes across the BBB compared with liposomes lacking the targeting moiety.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, brain tumor targeting is one of their most common applications mainly due to the ease of recognition by cancer cells as well [ 184 ]. Although targeting of TFR has been achieved with the aid of antibodies such as OX26 [ 218 ] and RI7-217 [ 217 ], they have shown different affinities within animal models (e.g., rats vs. mice) [ 234 ]. Similarly, antibodies have been employed for targeting the insulin growth factor receptor (IGFR), which is also highly expressed in the BBB and taken up by CME [ 235 ].…”
Section: Enhancing Ion Internalizationmentioning
confidence: 99%
“…Similar macrophage uptake has been observed in a long-acting dolutegravir prodrug encapsulated in a poloxamer nanoformulation [ 88 ]. To enhance transmigration across the BBB, nanoparticles utilizing a ferrous magnet-based liposome nanocarrier resulted in a 7.3-fold increase of transmigration with the synergistic support from transferrin receptors on the epithelium in vitro without affecting BBB integrity [ 92 ]. Similarly, the discovery of magnetic azidothymidine 5′-triphosphate (AZTTP) liposome demonstrated a threefold increase in migrating across the BBB compared with free AZTTP by utilizing the guidance of an external magnetic field to deliver the nanoparticle to a specific site of interest [ 93 ].…”
Section: Nanomedicine As a Vehicle To Cross The Bbb While Preserving mentioning
confidence: 99%